FABP4 and arrhythmogenic right ventricular cardiomyopathy: However, other target- and adipogenesis pathway-related genes, N-Cadherin, PPARγ, C/EBPα, and FABP4 increased by 4.13-, 5.28-, 8.77-, and 8.26-fold, respectively, in the ARVC group compared with the control group, (Figure 7D).